A Drosophila Model for Amyotrophic Lateral Sclerosis Reveals Motor Neuron Damage by Human SOD1
Overview
Affiliations
Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that leads to loss of motor function and early death. About 5% of cases are inherited, with the majority of identified linkages in the gene encoding copper, zinc-superoxide dismutase (SOD1). Strong evidence indicates that the SOD1 mutations confer dominant toxicity on the protein. To provide new insight into mechanisms of ALS, we have generated and characterized a model for familial ALS in Drosophila with transgenic expression of human SOD1. Expression of wild type or disease-linked (A4V, G85R) mutants of human SOD1 selectively in motor neurons induced progressive climbing deficits. These effects were accompanied by defective neural circuit electrophysiology, focal accumulation of human SOD1 protein in motor neurons, and a stress response in surrounding glia. However, toxicity was not associated with oligomerization of SOD1 and did not lead to neuronal loss. These studies uncover cell-autonomous injury by SOD1 to motor neurons in vivo, as well as non-autonomous effects on glia, and provide the foundation for new insight into injury and protection of motor neurons in ALS.
Shweta , Sharma K, Shakarad M, Agrawal N, Maurya S Mol Biol Rep. 2024; 51(1):1146.
PMID: 39532789 DOI: 10.1007/s11033-024-10075-w.
Human TDP43 is required for ALS‑related annexin A11 toxicity in .
Barnard J, Hunt R, Yucel M, Mazaud D, Smith B, Fanto M Biomed Rep. 2024; 21(5):165.
PMID: 39301564 PMC: 11411402. DOI: 10.3892/br.2024.1853.
Invertebrate genetic models of amyotrophic lateral sclerosis.
Zhou L, Xu R Front Mol Neurosci. 2024; 17:1328578.
PMID: 38500677 PMC: 10944931. DOI: 10.3389/fnmol.2024.1328578.
Zhu L, Li S, Li X, Yin P Transl Neurodegener. 2023; 12(1):46.
PMID: 37730668 PMC: 10510301. DOI: 10.1186/s40035-023-00377-7.
as a model to study autophagy in neurodegenerative diseases induced by proteinopathies.
Santarelli S, Londero C, Soldano A, Candelaresi C, Todeschini L, Vernizzi L Front Neurosci. 2023; 17:1082047.
PMID: 37274187 PMC: 10232775. DOI: 10.3389/fnins.2023.1082047.